Rutland Partners | Attends Healthcare
17140
page-template,page-template-full_width,page-template-full_width-php,page,page-id-17140,page-parent,ajax_fade,page_not_loaded,,vertical_menu_enabled,side_area_uncovered_from_content,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-16.8,qode-theme-bridge,disabled_footer_bottom,qode_header_in_grid,wpb-js-composer js-comp-ver-5.5.2,vc_responsive

Attends Healthcare

Investment Info

A European leader in the manufacture and supply of branded and own label incontinence products.

Sector:  Healthcare Products

Deal Value:  £94 million

Transaction:  Capex-led turnaround

Fund:  RFII

Exit Date:  January 2012

Exit Value:  £180 million

Exit Route:  Canadian trade buyer (Domtar)

Company website:  Attends

Investment Contact
Investment Contact